NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Nighttime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Cardinal Health 110, LLC. dba Leader | e7ad8d2d-01fd-40d9-a972-b2ca14cc97fb | 2026-04-09 | Warnings | 362O9ITL9D |
| Sinus and Headache Daytime | ACETAMINOPHEN, PHENYLEPHRINE HCL | L.N.K. International, Inc. | e20b1093-d77f-4c39-b105-adaa1b82ea76 | 2026-04-09 | Warnings | 362O9ITL9D |
| Oxycodone Hydrochloride and Acetaminophen | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | Elite Laboratories, Inc. | 27fa8190-d334-4bb9-b277-d1f44db433e3 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Cold and Flu Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Lidl US LLC | b26ac105-f8e4-4ad0-8a26-9fdf30c01700 | 2026-04-09 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Bryant Ranch Prepack | 5a7fb0e7-eb06-4332-a786-d0051afd1dd9 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Care One migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | American Sales Company | be6c9dc5-853e-4342-ba6a-e5b7be5afe72 | 2026-04-09 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Bryant Ranch Prepack | 679b4f87-59df-48d4-a9e6-e78aaeab23ea | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Bryant Ranch Prepack | d3b7f2b3-28c4-4ba5-961f-48e838600be2 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Sinus Pressure and Pain Maximum Strength | ACETAMINOPHEN, PHENYLEPHRINE HCL | Cardinal Health 110, LLC. DBA Leader | 80d25e23-b108-4eb1-88c7-73fe9da8f942 | 2026-04-09 | Warnings | 362O9ITL9D |
| Pain Reliever Childrens | ACETAMINOPHEN | H E B | 7e43de11-d20b-4920-a04d-3c1b5d35e005 | 2026-04-09 | Warnings | M013 362O9ITL9D |
| Tylenol Cold Plus Flu Plus Chest Congestion | ACETAMINOPHEN, GUAIFENESIN | Kenvue Brands LLC | 4e60e1ad-4ad4-c329-e063-6294a90ab318 | 2026-04-08 | Warnings | 362O9ITL9D |
| FreshKote Preservative Free Lubricant Eye Drops | POVIDONE, POLYVINYL ALCOHOL | Eyevance Pharmaceuticals | f51c50c3-43ae-4169-9d2b-22b239461dd1 | 2026-04-08 | Warnings | FZ989GH94E |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Navajo Manufacturing Company Inc. | f7e572e9-82a7-2127-e053-6394a90ab01a | 2026-04-08 | Warnings | M013 362O9ITL9D |
| Bayer Genuine Aspirin | ASPIRIN | Navajo Manufacturing Company Inc. | f6f2ce71-5728-aefb-e053-6394a90a20e4 | 2026-04-08 | Warnings | M013 |
| Midol | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Navajo Manufacturing Company Inc. | cabd10f2-a91e-4406-9249-915e306c867b | 2026-04-08 | Warnings | M013 362O9ITL9D |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Navajo Manufacturing Company Inc. | 4efbd21b-92fe-96a7-e063-6294a90ac4ad | 2026-04-08 | Warnings | 362O9ITL9D |
| Aspirin | ASPIRIN | HyVee Inc | 3730ee46-b241-44eb-94fa-52b9d12a9c35 | 2026-04-08 | Warnings | M013 |
| Aspirin | ASPIRIN | Walgreen Company | 82cc404b-fcf5-4e48-ab1a-09d8c47f9e04 | 2026-04-08 | Warnings | M013 |
| Menstrual Pain Relief Maximum Strength / Multi Symptom | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | DOLGENCORP, LLC | d441088b-fb1d-4fdc-954f-032f3122212f | 2026-04-08 | Warnings | 362O9ITL9D |
| MIGRAINE FORMULA | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Meijer, Inc. | 529b6ee6-043c-430a-b2e1-b63c81f10291 | 2026-04-08 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.